Exploration of Medicine

Table 2

Association rules statistics of HLA-I (A, B, and C) combinations of Mel and STS patients who received DCV immunotherapy

	Lhs¹	Rhs²	Support	Confidence	Cov³	Lift	Count⁴
1	HLA-B*13	HLA-C*06	0.0598	1.0000	0.0598	4.000	1
2	HLA-B*52	HLA-C*12	0.0598	1.0000	0.0598	4.182	11
3	HLA-A*25	HLA-B*18	0.0543	0.7692	0.0707	4.423	10
4	HLA-A*25	HLA-C*12	0.0597	0.8462	0.0707	3.538	11
5	HLA-B*14	HLA-C*08	0.0598	0.9167	0.0652	10.542	11
6	HLA-B*57	HLA-C*06	0.0924	1.0000	0.0923	4.000	17
7	HLA-B*08	HLA-A*01	0.0924	0.7727	0.1196	3.3852	17
8	HLA-B*08	HLA-C*07	0.1196	1.0000	0.1196	2.0909	22
9	HLA-B*40	HLA-C*03	0.0978	0.7200	0.1358	3.5805	18
10	HLA-B*35	HLA-C*04	0.1413	0.9286	0.1522	4.4962	26
11	HLA-B*07	HLA-C*07	0.1902	0.9459	0.2010	1.9779	35
12	HLA-B18, HLA-A25	HLA-C*12	0.0543	1.0000	0.0543	4.1818	10
13	HLA-C12, HLA-A25	HLA-B*18	0.0543	0.9091	0.0598	5.2273	10
14	HLA-B57, HLA-A01	HLA-C*06	0.0597	1.0000	0.0598	4.0000	11
15	HLA-B08, HLA-A01	HLA-C*07	0.0923	1.0000	0.0924	2.0909	17
16	HLA-B08, HLA-C07	HLA-A*01	0.0924	0.7727	0.1196	3.3853	17
17	HLA-C07, HLA-A01	HLA-B*08	0.0924	0.8095	0.1141	6.7706	17
18	HLA-B40, HLA-A02	HLA-C*03	0.0543	0.7692	0.0707	3.8254	10
19	HLA-B18, HLA-A02	HLA-C*07	0.0598	0.7333	0.0815	1.5333	11
20	HLA-B07, HLA-A02	HLA-C*07	0.0924	1.0000	0.0924	2.0909	17

Return to article view

¹ Lhs is left-hand-side or X in the association rule; ² Rhs is right-hand-side or Y in the association rule; ³ Coverage is a proportion of observations in the full dataset that comply with the rule; ⁴ Count of the observations with the rule. Mel: melanoma; STS: soft tissue sarcomas; DCV: dendritic cell vaccine